Markets:

Overview

News

Currencies

International

Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

277.28 -3.55 (-1.26%)

Streaming Delayed Price Updated: 10:48 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

2 Safe-and-Steady Stocks with Solid Fundamentals and 1 We Question

January 04, 2026

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Topics Economy

The Biotech Revolution’s Ultimate ‘Picks and Shovels’ Play: A Deep Dive into West Pharmaceutical Services (WST)

December 23, 2025

As the pharmaceutical industry undergoes its most significant transformation in decades, the spotlight often falls on the blockbuster drugs themselves—the weight-loss miracles and the life-saving...

Via MarketMinute

Topics Economy

Picks and Shovels of the Biotech Revolution: A Deep Dive into West Pharmaceutical Services (WST)

December 23, 2025

Date: December 23, 2025 Introduction In the high-stakes world of biotechnology and pharmaceutical manufacturing, few companies are as indispensable yet as quietly influential as West Pharmaceutical...

Via PredictStreet

Topics Economy Intellectual Property Supply Chain

Earnings Scheduled For October 23, 2025 ↗

October 23, 2025

Via Benzinga

1 S&P 500 Stock Worth Your Attention and 2 We Avoid

December 15, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Economy Stocks

3 Profitable Stocks We Approach with Caution

December 11, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Topics Economy

3 Reasons WST is Risky and 1 Stock to Buy Instead

December 03, 2025

West Pharmaceutical Services’s 34.6% return over the past six months has outpaced the S&P 500 by 20.2%, and its stock price has climbed to $284.57 per share. This was partly thanks to its solid...

Via StockStory

Topics Stocks

1 Healthcare Stock with Promising Prospects and 2 We Question

December 02, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized strong financial performance, and over the past...

Via StockStory

Topics Economy Stocks

Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

Looking Into West Pharmaceutical Services Inc's Recent Short Interest ↗

November 20, 2025

Via Benzinga

Winners And Losers Of Q3: West Pharmaceutical Services (NYSE:WST) Vs The Rest Of The Drug Development Inputs & Services Stocks

November 06, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at drug development inputs & services stocks,...

Via StockStory

Topics Economy

1 High-Flying Stock on Our Watchlist and 2 Facing Challenges

October 31, 2025

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,...

Via StockStory

Topics Economy

The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q3 Earnings Call

October 30, 2025

West Pharmaceutical Services delivered third quarter results that surpassed Wall Street’s revenue and profit expectations, sparking a strong positive reaction in the market. Management attributed this...

Via StockStory

Topics Earnings

Exploring the top movers within the S&P500 index during today's session. ↗

October 27, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

Via Chartmill

These S&P500 stocks are moving in today's session ↗

October 27, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday.

Via Chartmill

Demystifying West Pharmaceutical Servs: Insights From 5 Analyst Reviews ↗

October 24, 2025

Via Benzinga

WST Q3 Deep Dive: GLP-1 Demand, Annex 1 Upgrades, and Margin Expansion Shape Outlook

October 24, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $804.6 million. The...

Via StockStory

Why West Pharmaceutical Services Stock Was Blasting Higher on Thursday ↗

October 23, 2025

The company crushed analyst profitability estimates, both for its trailing quarter and for its full-year guidance.

Via The Motley Fool

Why Are West Pharmaceutical Services (WST) Shares Soaring Today

October 23, 2025

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 12.3% in the afternoon session after the company reported strong third-quarter 2025 results that surpassed analyst...

Via StockStory

Topics Artificial Intelligence Earnings Supply Chain

Thursday's session: top gainers and losers in the S&P500 index ↗

October 23, 2025

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

WST Stock Soars After Company Raises Full-Year Guidance On Strong Demand For GLP-1 Drug Components ↗

October 23, 2025

The Pennsylvania-headquartered company raised its full-year net sales guidance to $3.06 billion to $3.07 billion, up from $3.04 billion to $3.06 billion.

Via Stocktwits

Topics Artificial Intelligence Earnings

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

October 23, 2025

In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Thursday's session.

Via Chartmill

Oil Stocks Rally On Trump's Russia Sanctions: What's Moving Markets Thursday? ↗

October 23, 2025

Energy markets dominated headlines Thursday as a fresh wave of U.S. sanctions targeting Russia's oil giants sparked a sharp rebound in crude prices and lifted energy shares.

Via Benzinga

Topics Government

Discover which S&P500 stocks are making waves on Thursday. ↗

October 23, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand ↗

October 23, 2025

West Pharmaceutical posts Q3 earnings of $1.96 per share and raises 2025 guidance, driven by GLP-1 demand and strong HVP component growth.

Via Benzinga

These S&P500 stocks are gapping in today's session ↗

October 23, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Thursday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday ↗

October 23, 2025

Via Benzinga

Topics Stocks

Wondering what's happening in today's S&P500 pre-market session? ↗

October 23, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.

Via Chartmill

West Pharmaceutical Services (NYSE:WST) Q3 2025 Earnings Top Estimates, Boosts Full-Year Outlook ↗

October 23, 2025

West Pharmaceutical Services (WST) beats Q3 2025 earnings and revenue estimates, raises full-year guidance. The strong results, led by an EPS beat, sent the stock up over 6% pre-market.

Via Chartmill

West Pharmaceutical Services’s (NYSE:WST) Q3 Sales Beat Estimates

October 23, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $804.6 million. The...

Via StockStory

Topics Earnings Economy

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.